Optimize Portfolio Insights, Prioritization, and Decision Making for Pharma and Biotech

Visit the New Site

Stay up-topdate on the 2025 conference and agenda: Visit the new Executive Project, Program & Portfolio Management Summit website EP3MSummit.com

CONTINUE TO NEW WEBSITE »





Strategic Resource Management
Tools and Strategies to Enhance R&D Productivity, Forecasting, and Planning
10/9/2024 - October 10, 2024 ALL TIMES EDT
The ebb and flow of drug development timelines presents huge challenges to the biopharma R&D community in terms of resource management, forecasting, and capacity planning. To manage the inherent risks of delays and product failure, companies must develop efficient performance planning, intelligent partnering, and data analytics to create and sustain agile resource management systems and processes that align with portfolio priorities. Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ 21st Annual Strategic Resource Management: Tools and Strategies to Enhance R&D Productivity, Forecasting, and Planning gathers seasoned biopharma strategic and operational leaders to delve into new approaches and share best practices to improve resource and capacity management and enhance R&D productivity.

Wednesday, October 9

Registration Open

Chairperson's Remarks

Peter Ray, Vice President, Head of Portfolio & Decision Analytics, Novartis , VP & Head , Portfolio Analytics , Novartis

KEYNOTE PRESENTATION:
Unlock the Power of Change: Elevate Your Leadership Journey

Photo of Mary Lou Panzano, Founder and CEO, Panzano Enterprises LLC; former Vice President, Internal Communications, Bayer , Founder & CEO , Panzano Enterprises LLC
Mary Lou Panzano, Founder and CEO, Panzano Enterprises LLC; former Vice President, Internal Communications, Bayer , Founder & CEO , Panzano Enterprises LLC
Photo of Michelle Shogren, CEO & Owner, Innovate in What You Do!; former Senior Director of Innovation, Pharma R&D Clinical Operations, Bayer , CEO/Owner , Innovate in What You Do! LLC
Michelle Shogren, CEO & Owner, Innovate in What You Do!; former Senior Director of Innovation, Pharma R&D Clinical Operations, Bayer , CEO/Owner , Innovate in What You Do! LLC

As a forward-thinking leader, you wield the power to orchestrate transformative change within your organization. Yet, amidst the dynamic landscape of progress, do you possess the essential toolkit to navigate inevitable challenges and conflicts, ensuring collaboration prevails over escalation? Join us for an engaging session where you'll uncover not only the five critical pillars of effective change management but also strategies for adept conflict resolution. Gain invaluable insights to steer your organization towards a future of innovation, resilience, and sustainable growth. Seize this transformative opportunity to elevate your leadership prowess and drive impactful change.

KEYNOTE PRESENTATION:
Employing AI to Increase R&D Productivity

Photo of Mathilde Bryse, Head of R&D Strategy, Sanofi , Head of R&D Strategy , Sanofi
Mathilde Bryse, Head of R&D Strategy, Sanofi , Head of R&D Strategy , Sanofi

Sanofi, a pharmaceutical company of 100,000+ employees that develops medicines and vaccines, began a business transformation in portfolio management, leveraging artificial intelligence (AI) as a key accelerator. As part of our business transformation, we've co-developed a decision intelligence tool called PLai that correlates >1B data points in a single source of truth, and leverages AI to make recommendations from strategy to operations.  We use AI predictions to challenge our internal view on key parameters. 

Breakouts

BREAKOUT DISCUSSIONS (IN PERSON ONLY)

Breakout Discussions

Breakout Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing. Please visit the Breakout Discussions page on the conference website for a complete listing of topics and descriptions.

IN-PERSON ONLY BREAKOUT:
TABLE 4: Balancing Internal R&D Investments and Resources with External Collaborations

Elayne Ko, Director, Portfolio Decision Sciences, GSK , Dir Portfolio Decision Sciences , Portfolio Decision Sciences , GSK

Gregory Wayne, PhD, Head, Decision Sciences Group, AbbVie, Inc. , Head, Decision Sciences Group , Decision Sciences Group , AbbVie Inc

  • What analysis do you use to evaluate investments and resource planning?
  • How do you prioritize resources when evaluating both internal and external projects against each other?​

IN-PERSON ONLY BREAKOUT:
TABLE 5: Applicability of AI within Project Decision-Making and Portfolio Management: Where and When would AI Be Relevant and Applicable

Mathilde Bryse, Head of R&D Strategy, Sanofi , Head of R&D Strategy , Sanofi

Joe Stalder, Vice President, Program Management, Zentalis Pharmaceuticals , Vice President , Program Management , Zentalis Pharmaceuticals

  • Where have you seen application of AI in decision making and project management?
  • At what specific areas and stages is AI likely to bring significant value?What potential pitfalls and roadblocks should teams be on the lookout for?​

IN-PERSON ONLY BREAKOUT:
TABLE 6: Influencing, Initiating and Executing Organizational Change Management

Stephen Cho, PhD, President, SSC Strategic Advisors LLC. , Head , Portfolio Strategy & Analytics, Strategy & Growth , SSC Strategic Advisors LLC

Paul B. Cook, PhD, Principal, Bridging Solutions, LLC , Principal , Bridging Solutions, LLC

Leslie Lippard, Director, Product & Portfolio Strategy, BioMarin Pharmaceutical Inc , Sr Dir , Portfolio Analytics , Alnylam Pharmaceuticals

  • How do you identify sources of the organizations pain points?
  • How to say “no” or “not now” to all of the great ideas and proposed projects
  • What are the differences between project management and change management, and how do you integrate them to deliver positive outcome to the organization?

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
Simplifying Portfolio and Resource Management Processes in the Age of Analytics

Photo of Mike Myers, Founder & President, ID4 Consulting , Associate Vice President , LRL Due Diligence , Eli Lilly & Company
Mike Myers, Founder & President, ID4 Consulting , Associate Vice President , LRL Due Diligence , Eli Lilly & Company

Panelists:

Photo of Melquiades de Jesus, Senior Director, R&D PMO Business Capabilities, Jazz Pharmaceuticals , Senior Director , R&D PMO Business Capabilities , Jazz Pharmaceuticals
Melquiades de Jesus, Senior Director, R&D PMO Business Capabilities, Jazz Pharmaceuticals , Senior Director , R&D PMO Business Capabilities , Jazz Pharmaceuticals
Photo of Mathilde Bryse, Head of R&D Strategy, Sanofi , Head of R&D Strategy , Sanofi
Mathilde Bryse, Head of R&D Strategy, Sanofi , Head of R&D Strategy , Sanofi
Photo of Leslie Lippard, Director, Product & Portfolio Strategy, BioMarin Pharmaceutical Inc , Sr Dir , Portfolio Analytics , Alnylam Pharmaceuticals
Leslie Lippard, Director, Product & Portfolio Strategy, BioMarin Pharmaceutical Inc , Sr Dir , Portfolio Analytics , Alnylam Pharmaceuticals
Photo of Peter Ray, Vice President, Head of Portfolio & Decision Analytics, Novartis , VP & Head , Portfolio Analytics , Novartis
Peter Ray, Vice President, Head of Portfolio & Decision Analytics, Novartis , VP & Head , Portfolio Analytics , Novartis

Close of Day

Thursday, October 10

Registration and Morning Coffee

DELIVERING ON PROGRAM & PORTFOLIO STRATEGY

Chairperson's Remarks

Sean Gallagher, Director, Capacity Management and Business Analytics, Johnson & Johnson , Director , Capacity Management and Business Analytics , Janssen Pharmaceuticals Inc

Linking Portfolio Intent to Resource Deployment: Best Practices to Enhance Operational Efficiency and Effectiveness

Photo of Michael Ferrante, Executive Director, Business Analytics, Global Regulatory Affairs & Clinical Safety, Merck , Executive Director, Business Analytics , Global Regulatory Affairs & Clinical Safety , Merck & Co
Michael Ferrante, Executive Director, Business Analytics, Global Regulatory Affairs & Clinical Safety, Merck , Executive Director, Business Analytics , Global Regulatory Affairs & Clinical Safety , Merck & Co

Effective resource allocation is crucial for achieving organizational goals and optimizing project success. This presentation explores the strategic alignment of portfolio intent with resource allocation, emphasizing the importance of ensuring coherence between company objectives and resource distribution. By leveraging data analysis and forecasting techniques, organizations can make informed decisions to balance resource demand and capacity, thereby enhancing operational efficiency and effectiveness. Case studies and real-world examples will illustrate the positive impact of linking portfolio intent to resource deployment, showcasing how this alignment fosters project success and drives overall business growth.

Implementation of Resource/Capacity Management through Integration with Portfolio Management

Photo of Stuart Fort, Senior Director, Project Management Strategy and Capabilities, Eli Lilly and Company , Senior Director , Project Management Strategy and Capabilities , Eli Lilly and Company
Stuart Fort, Senior Director, Project Management Strategy and Capabilities, Eli Lilly and Company , Senior Director , Project Management Strategy and Capabilities , Eli Lilly and Company

Common challenges in capacity management systems involve maintaining real-time demand data while also dealing with the differing structures and needs of each function in the R&D value chain. This presentation highlights a solution that leverages an existing project and portfolio management system and layers in the resource structure in a flexible and sustainable manner, and putting real-time resource and capacity management analyses in the hands of each functional leader.

Networking Coffee Break

Expanded Use of AI and Data Science in Resource Forecasting and Planning

Photo of Thomas De Vis, Associate Director Capacity Management, Johnson & Johnson , Assoc Dir Capacity Mgmt , Johnson & Johnson
Thomas De Vis, Associate Director Capacity Management, Johnson & Johnson , Assoc Dir Capacity Mgmt , Johnson & Johnson

Embark on a journey into the future of resource forecasting and planning in pharmaceuticals and biotech with Thomas De Vis. Discover how AI and data science are revolutionizing decision-making processes and optimizing resource allocation for enhanced efficiency. Gain actionable insights into leveraging advanced analytics for strategic resource management. Join us for an engaging exploration, featuring a compelling case study from Johnson & Johnson. Don't miss this opportunity to unlock the full potential of AI-driven resource optimization in your organization.

Panel Moderator:

PANEL DISCUSSION:
Opportunities to Drive Value: Implementing Fit-for-Purpose Resource Forecasting Capabilities in a Dynamic Environment

Saeid (Sam) Yazdani, Senior Director, Project, Program & Portfolio Management – Drug Development, argenx , VP Portfolio & Program Mgmt , Therapeutics Product Dev , Caribou Biosciences Inc

Panelists:

Michael Ferrante, Executive Director, Business Analytics, Global Regulatory Affairs & Clinical Safety, Merck , Executive Director, Business Analytics , Global Regulatory Affairs & Clinical Safety , Merck & Co

Stuart Fort, Senior Director, Project Management Strategy and Capabilities, Eli Lilly and Company , Senior Director , Project Management Strategy and Capabilities , Eli Lilly and Company

Andrea James, Senior Director, Head of Portfolio Resource Forecasting, Merck , Sr. Director, Head of Portfolio Resource Forecasting , Portfolio Resource Forecasting , Merck

Networking Luncheon

RESOURCE PLANNING & FORECASTING TO SUPPORT SHIFTING PRIORITIES

Chairperson's Remarks

Alexander Rucci, Director, Project Management, Sumitomo Pharma America , Director , Project Management , Sumitomo Pharma America, Inc.

Optimizing Resource Allocation—Approaches for Internal, External, and Regional Sourcing

Photo of Sabine Lenders, Associate Director, Capacity Management, Johnson & Johnson Innovative Medicine , Associate Director Capacity Management , GD, BGIA, PPR , Johnson & Johnson Innovative Medicine
Sabine Lenders, Associate Director, Capacity Management, Johnson & Johnson Innovative Medicine , Associate Director Capacity Management , GD, BGIA, PPR , Johnson & Johnson Innovative Medicine

This session will delve into strategies to maximize organizational efficiency through internal collaboration, strategic external partnerships, and regional considerations. Discover insights, case studies, and decision frameworks essential for executives navigating complex resource allocation challenges. Join us to unlock the potential of your resource management endeavors.

Increasing Employee Efficiency Post-Portfolio Re-Prioritization and Company Transformation

Photo of Alexander Rucci, Director, Project Management, Sumitomo Pharma America , Director , Project Management , Sumitomo Pharma America, Inc.
Alexander Rucci, Director, Project Management, Sumitomo Pharma America , Director , Project Management , Sumitomo Pharma America, Inc.

In early 2024 SMPA announced a major organizational restructuring including, a rationalization of workforce along with major changes to our biggest partnership. The Global Corporate Strategy team needed to develop new processes that track key strategic metrics across the finance, resource, and milestones spaces. This presentation will show our team's approach to this opportunity, along with a strategy to implement results.

Updating Resource Management/Forecasting for in-House Studies

Photo of Jennifer Daubenspeck, PhD, Associate Director, GMPO Systems & Integration, Jazz Pharmaceuticals , Associate Director, Business Capabilities , Jazz Pharmaceuticals
Jennifer Daubenspeck, PhD, Associate Director, GMPO Systems & Integration, Jazz Pharmaceuticals , Associate Director, Business Capabilities , Jazz Pharmaceuticals

Clinical trial work has traditionally been outsourced at Jazz. As we shift to supporting some studies in-house, we needed to update the resource forecasting algorithms for many roles. We worked with many stakeholders and minimal historical data to develop the new algorithms. Understating the high level of uncertainty (known unknowns and unknown unknowns), we are designing a flexible solution meant to evolve.

Closing Remarks

Alexander Rucci, Director, Project Management, Sumitomo Pharma America , Director , Project Management , Sumitomo Pharma America, Inc.

Close of Strategic Resource Management Conference


For more details on the conference, please contact:

Bridget Kotelly

Senior Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-264-5249

Email: bkotelly@cambridgeinnovationinstitute.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com

Download Brochure

For more details on the conference, please contact:

Bridget Kotelly
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5404
Email:
bkotelly@cambridgeinnovationinstitute.com


Program and Portfolio Management